fbpx

Prisme Optical Group Welcomes a New US National Sales Manager

Prisme Optical Group has announced the appointment of Guillaume Pottecher as the new United States, National Sales Manager. He will report to Carole Menard, Vice President of Sales.

Guillaume brings 15 years of industry knowledge and established relationships and extensive experience in the high end segment of the optical industry. Guillaume introduced the brand Tag Heuer to the US market and has worked with De Rigo. Guillaume will be responsible for: sales, networking, territory development and training, recruiting qualified representatives, business relations for groups and important key accounts in the US.

Prisme Optical Group is a North American leader in the distribution of high end frames including brands, such as Beausoleil, Oliver Goldsmith Spectacle, Xavier Garcia Barcelona and Tartine & Chocolat.

www.prismeoptical.com

Screen shot 2015-02-17 at 4.41.21 PM

Essilor Reports 12% Revenue Growth in 2014

With revenue up 12% and operations up 15.4%, Essilor maintained its growth in 2014.

Forty-five percent of the French giant’s revenue came from North America. Growth in Canada was supported by Varilux, Crizal, Transitions and Xperio, the impact of the “perfect pair” offer and the company’s widening presence in the mass retailing channel. The introduction of Kodak lenses and the partnership with Riverside Optical labs contributed to expansion in the mid-tier.

Looking beyond the figures, 2014 marked a strategic shift at Essilor.  CEO Hubert Sagnières calls the group’s desire to expand its playing field, namely in photochromics, sunwear and online business, a true “cultural revolution.” This strategy was embodied in the acquisitions of Transitions Optical, Coastal.com and Costa, as well as in its collaborative effort with FGX International in a sunglass offering.

One in Four Toronto Homeless Have Vision Problems

A survey by Saint Michael’s Hospital in Toronto found that 25% of homeless people have vision problems, rising to 35% when other eye abnormalities are included. This is four times higher than the North American average.

Of the respondents in need of vision care, 40% would benefit from glasses or contact lenses while 8% required urgent referral to an ophthalmologist. One in three respondents had been previously diagnosed with vision problems.

61 respondents had worn prescription glasses in the past. 43 reported that their glasses had been lost, stolen or broken and could not afford a replacement.

Researchers recommend introducing mobile eye screening centres, which include free eye exams and corrective eyewear. Similar programs have been successful in the United States, the United Kingdom, Costa Rica and South Africa.

Only 14% of those surveyed had visited an ophthalmologist or optometrist within the last year compared with 41% of the general population. 89% of respondents expressed an interest in free eye exams.

For more information: http://www.sciencedaily.com/releases/2015/02/150205123111.htm

A Vaccine Against Eye Cancer

Researchers are currently testing a vaccine that improves the chances of recovery of patients with ocular tumors by stimulating their immune response.

Choroidal melanoma is the most common ocular malignancy. If it is not treated quickly enough, metastases develop and can cause death. Researchers at the University Hospital of Erlangen, Germany, have developed a vaccine to prevent the development of metastases.

Dendritic cells typically trigger the immune response after recognizing a threat. However, in cancer patients, the tumor often blocks the immune response. The new vaccine contains custom dendritic cells and triggers the immune response, which delays or prevents the formation of metastases.

Right now, 200 German patients involved in the study of the vaccine.

 

Laser 1, AMD 0

A new laser treatment administered during early stages of age-related macular degeneration may slow, even reverse, the progression of the disease.

The new technique involving nanosecond laser may also have implications for other eye diseases such as diabetic macular oedema, diabetic retinopathy and retinopathy of prematurity.

A study conducted on humans and mice showed that treatment using low-energy nanosecond laser limits the progression of the disease, without damaging the retina. Furthermore, treatment in one eye can also produce positive effects in the other untreated eye.

Gerald Weissmann, editor-in-chief of The FASEB Journal, which published the findings, believes that this research could “usher in an era in which age-related macular degeneration is either eliminated or no longer considered a serious disease.”

For further information: http://www.sciencedaily.com/releases/2015/02/150202105602.htm

Featured Posts

Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Learn More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris Set to Become the Global Capital of Eyewear and Optics in One Month

SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.

Read more
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Learn More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read More
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read More
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read More
Silmo Paris nouvelle image de marque 2026

SILMO Paris Set to Become the Global Capital of Eyewear and Optics in One Month

SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.

Read More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Learn More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris Set to Become the Global Capital of Eyewear and Optics in One Month

SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.

Read more
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Learn More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Silmo Paris nouvelle image de marque 2026

SILMO Paris Set to Become the Global Capital of Eyewear and Optics in One Month

SILMO Paris returns 25–28 September, bringing together global eyewear and optical professionals for four days of innovation, trends, conferences and industry dialogue.

Read more